A recent retrospective study found that performing Chronic Total Occlusion Percutaneous Coronary Intervention (CTO-PCI) ...
Aplagon is also planning for 2026 a Phase 2 clinical trial for arteriovenous fistula (AVF) maturation failure in Europe, following the successful completion of its Phase 1 AVF trial. The study ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果